Filter News
Area of Research
- (-) Materials (12)
- Advanced Manufacturing (1)
- Biology and Environment (3)
- Clean Energy (15)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (3)
- Materials for Computing (3)
- National Security (2)
- Neutron Science (3)
- Nuclear Science and Technology (18)
- Supercomputing (5)
News Topics
- (-) Composites (2)
- (-) Cybersecurity (1)
- (-) Isotopes (5)
- (-) Nuclear Energy (4)
- (-) Transportation (3)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (1)
- Artificial Intelligence (2)
- Big Data (2)
- Bioenergy (4)
- Biomedical (3)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (9)
- Coronavirus (1)
- Critical Materials (2)
- Energy Storage (7)
- Environment (3)
- Exascale Computing (1)
- Grid (1)
- Machine Learning (3)
- Materials (1)
- Materials Science (25)
- Mathematics (1)
- Microscopy (5)
- Molten Salt (1)
- Nanotechnology (14)
- National Security (1)
- Neutron Science (12)
- Physics (10)
- Polymers (4)
- Quantum Science (4)
- Security (1)
- Summit (2)
- Sustainable Energy (4)
- Transformational Challenge Reactor (2)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...